Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Neoplasms 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Retinoblastoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Osteoporosis 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma, Mantle-Cell 1

Interventions

HhAntag691 15 sonidegib 5 cemiplimab 5 Nivolumab 5 Aminolevulinic Acid 5 daromun 4 Specimen Handling 4 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 3-ingenyl angelate 3 tazarotene 2 relatlimab 2 Ipilimumab 2 IPI-926 2 Drug Evaluation 2 Celecoxib 2 Biopsy 2 talimogene laherparepvec 1 remetinostat 1 gusacitinib 1 endonuclease V, phage T4 1 X-Rays 1 Triamcinolone 1 Sutures 1 Surgical Procedures, Operative 1 Solutions 1 Papillomavirus Vaccines 1 Opdualag 1 Observation 1 Niacinamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Basal Cell × Observation × Clear all

NCT05561634 2025-09-30

RADIOSONIC

University Hospital, Lille

Phase 2 Recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡